Survival following Burkholderia cepacia sep... [Pediatr Pulmonol. 2001] - PubMed

loading

Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness. [Pediatr Infect Dis J. 2004]
Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness.
Johnson LN, Han JY, Moskowitz SM, Burns JL, Qin X, Englund JA. Pediatr Infect Dis J. 2004 Sep; 23(9):881-2.
Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis. [Can Respir J. 2006]
Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis.
George RB, Cartier Y, Casson AG, Hernandez P. Can Respir J. 2006 May-Jun; 13(4):215-8.
Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis. [J Cyst Fibros. 2006]
Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
Lekkas A, Gyi KM, Hodson ME. J Cyst Fibros. 2006 May; 5(2):121-4.
Review Advances in Burkholderia cepacia complex. [Paediatr Respir Rev. 2002]
Review Advances in Burkholderia cepacia complex.
Speert DP. Paediatr Respir Rev. 2002 Sep; 3(3):230-5.
Review Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. [Curr Opin Pulm Med. 1998]
Review Burkholderia cepacia epidemiology and pathogenesis: implications for infection control.
LiPuma JJ. Curr Opin Pulm Med. 1998 Nov; 4(6):337-41.

Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence. [J Cyst Fibros. 2010]
Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence.
Taylor JB, Hogue LA, LiPuma JJ, Walter MJ, Brody SL, Cannon CL. J Cyst Fibros. 2010 Jan; 9(1):36-43. Epub 2009 Nov 14.
Cystic fibrosis, a Burkholderia cenocepacia chest wall abscess and rapid clinical deterioration. [J R Soc Med. 2008]
Cystic fibrosis, a Burkholderia cenocepacia chest wall abscess and rapid clinical deterioration.
Simmonds NJ, Gyi KM. J R Soc Med. 2008 Jul; 101 Suppl 1:S46-50.
Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis. [Can Respir J. 2006]
Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis.
George RB, Cartier Y, Casson AG, Hernandez P. Can Respir J. 2006 May-Jun; 13(4):215-8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis...
Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids.
Pediatr Pulmonol. 2001 Oct ;32(4):338-40.

PubMed
Combined transplantation of the heart, lung, and liver.
Combined transplantation of the heart, lung, and liver.
Lancet. 2001 Sep 8 ;358(9284):812-3.

PubMed
11564492[uid] (1)
PubMed
Administration of aerosolized antibiotics in cystic fibrosis patients.
Administration of aerosolized antibiotics in cystic fibrosis patients.
Chest. 2001 Sep ;120(3 Suppl):107S-113S.

PubMed
Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and ef...
Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy.
Acta Paediatr. 2001 Aug ;90(8):860-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed